Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Allergology International : Official Journal of the Japanese Society of Allergology|April 23, 2008
Human Th17 cell clones and natural immune responsesSho Matsushita, Takehiro Higashi
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 13, 2026
[Sequential development of BCR::ABL1-positive chronic myeloid leukemia during treatment of JAK2 V617F-positive essential thrombocythemia]Midori Goto, Takehiro Higashi, Hiroaki Morimoto, et al.
International Archives of Allergy and Immunology|June 8, 2011
Qualitative evaluation of adjuvant activities and its application to Th2/17 diseasesSho Matsushita, Rie Takagi, Kumiko Hashimoto, et al.
Biomarker Research|May 13, 2015
Reversible methotrexate-associated lymphoma of the liver in rheumatoid arthritis: a unique case of primary hepatic lymphomaAi Kawahara, Junichi Tsukada, Takahiro Yamaguchi, et al.
Biochemical and Biophysical Research Communications|June 19, 2008
Antagonizing dopamine D1-like receptor inhibits Th17 cell differentiation: preventive and therapeutic effects on experimental autoimmune encephalomyelitisKazuhisa Nakano, Takehiro Higashi, Kumiko Hashimoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 9, 2017
[Efficacy and Safety of THP-COP for Diffuse Large B-Cell Lymphoma]Midori Watase, Kojiro Takahashi, Naoko Hanazawa, et al.
International Immunology|April 1, 2009
Dopamine released by dendritic cells polarizes Th2 differentiationKazuhisa Nakano, Takehiro Higashi, Rie Takagi, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|May 23, 2008
Evaluation of adjuvant activities using human antigen presenting cells in vitroTakehiro Higashi, Masatoshi Wakui, Kazuhisa Nakano, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2008
B cell chemoattractant CXCL13 is preferentially expressed by human Th17 cell clonesRie Takagi, Takehiro Higashi, Kumiko Hashimoto, et al.
Pageof 4